Project Grant HT94252410023
Award Date
12/15/23
Completion Date
12/14/26
Dollars Obligated
$693K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
The Defense Health Agency awarded Wayne State University a $616,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate the molecular mechanisms and therapeutic potential of the RNA methyltransferase FTSJ3 in regulating ribosome biogenesis in liver cancer. The project will be conducted over a 2-year period from September 30, 2023 to September 29, 2025. As a premier public research university, Wayne State University has a track record of...
This $924,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University to target dual-specificity phosphatase 1 in platinum resistance in ovarian cancer. The award, which runs from July 1, 2024 to June 30, 2028, will enable Wayne State to conduct innovative scientific studies to improve treatment options and outcomes for this challenging form of cancer, which disproportionately impacts...
Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
The Project Grant award of $400,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund research at Wayne State University to "HARNESS IMMUNOMETABOLISM TO AMELIORATE THE PATHOLOGY OF OCULAR CHEMICAL INJURIES". The project will run from July 1, 2025 to June 30, 2027 and aims to develop innovative medical solutions to address health challenges faced by military service members. Wayne State University, a prominent public research...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,844,306.00 Project Grant to the Regents of the University of Michigan on September 1, 2025. The grant, titled "COTARGETING NSD1/2 PARALOGS IN AR-DRIVEN CASTRATION-RESISTANT PROSTATE CANCER," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative medical...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
The Department of Defense's Defense Health Agency awarded a $620,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Henry Ford Health System in Detroit, Michigan. The grant, awarded on September 30, 2025, with a completion date of September 29, 2027, supports the development of plasmacytoid DC exosomes as a new type of cancer vaccine that overcomes CDC1 dependence and tumor immunosuppression. The funding will enable the Henry Ford Health System,...
The U.S. Department of Defense's Defense Health Agency has awarded a $780,000 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "LEAD EXPOSURE AND SEX-SPECIFIC PROGRAMMING OF CARDIOVASCULAR DISEASE ACROSS THE LIFE COURSE", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate...
The University of Michigan will receive $1,169,999 under a three-year Project Grant award from the Department of the Army Medical Command to identify therapeutic vulnerabilities of bone marrow-driven recurrence of ER+ breast cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield medicine and investigations into medical...
Duke University was awarded a $931,969 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to develop epigenetic signatures to predict pathological nodal stage for de-escalation of axillary surgery in patients with clinically node-positive breast cancer. The research aims to transform patient care by investigating medical solutions that could help reduce the need...